Professional Summary
Professional Overview
Chris Doyle is an experienced Chief Financial Officer with a proven track record of driving financial strategy and operational excellence across the consumer and retail industries. With a diverse background spanning investment banking, private equity, and financial management roles, he brings a unique blend of strategic and analytical capabilities to his current positions at Seraphina Therapeutics and fatty15.
Experience Summary
Current Roles
As the Chief Financial Officer at Seraphina Therapeutics and fatty15, Chris is responsible for overseeing all financial operations, including financial planning and analysis, capital allocation, and risk management. He plays a crucial role in aligning the companies' financial strategies with their overall business objectives, driving sustainable growth and profitability.
Career Progression
Prior to his current roles, Chris served as the Chief Financial Officer and Head of Finance at Diggs Pet, where he was instrumental in implementing cost-saving initiatives and streamlining financial processes to enhance the company's operational efficiency. Before that, he held various finance leadership positions at Mars, including Global Finance Director for the KIND and Nature's Bakery brands, and Senior Finance Manager for the Mars Wrigley business development team.
Chris began his career in investment banking, working as an Associate at Moelis & Company, where he advised clients in the consumer and retail sectors on mergers, acquisitions, and capital-raising activities. He also gained valuable experience as a Private Equity Associate at Nebrodi Partners LLC, where he participated in the evaluation and execution of investment opportunities.
Academic Background
Chris holds an MBA from the Yale School of Management, where he specialized in finance and strategy. He also earned a bachelor's degree, with distinction, from the University of Virginia.
Areas of Expertise
- Financial planning and analysis
- Capital allocation and risk management
- Strategic decision-making
- Mergers, acquisitions, and capital markets
- Operational efficiency and cost optimization
- Leadership and team management
Professional Impact
During his tenure at Diggs Pet, Chris implemented a comprehensive cost-saving program that resulted in a 15% reduction in operating expenses, while also securing a $20 million Series B funding round to support the company's growth initiatives. At Mars, he played a pivotal role in the successful integration of the KIND and Nature's Bakery brands, driving synergies and enhancing profitability across the portfolio.
Conclusion
With his extensive experience in the consumer and retail sectors, Chris Doyle is a seasoned financial leader who excels at aligning financial strategies with business objectives to drive sustainable growth and profitability. In his current roles at Seraphina Therapeutics and fatty15, he is poised to leverage his strategic and analytical expertise to navigate complex financial challenges and contribute to the companies' long-term success.
